In melanoma, one of the first TAAs verified was melanocyte lineage-specific protein (MART-1), and its immunodominant epitope MART-127-35 was recognized by HLA-A2-restricted cytotoxic T lymphocytes (CTLs) derived from some melanoma patients (6). This evidence concerns the gene SEPTIN4 and melanoma.